Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
67
UBS Quote, Financials, Valuation and Earnings
Last price:
$32.28
Seasonality move
:
4.59%
Day range:
$33.29 - $33.86
52-week range:
$25.75 - $35.84
Dividend yield:
1.33%
P/E ratio:
22.35x
P/S ratio:
2.47x
P/B ratio:
1.23x
Volume:
5.7M
Avg. volume:
3.4M
1-year change:
11.24%
Market cap:
$107.6B
Revenue:
$45.3B
EPS (TTM):
$1.51
Analysts' Opinion
-
Consensus RatingUBS Group AG has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $31.60, UBS Group AG has an estimated downside of -6.37% from its current price of $33.75.
-
Price Target UpsideAccording to analysts, the highest upside price target is $31.70 representing -100% upside increase from its current price of $33.75.
Fair Value
-
According to the consensus of 1 analyst, UBS Group AG has -6.37% downside to fair value with a price target of $31.60 per share.
UBS vs. S&P 500
-
Over the past 5 trading days, UBS Group AG has overperformed the S&P 500 by 3.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
UBS Group AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UBS Group AG revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter UBS Group AG reported revenues of $11.4B.
Earnings Growth
-
UBS Group AG earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter UBS Group AG reported earnings per share of $0.51.
Enterprise value:
202.5B
EV / Invested capital:
0.48x
Price / LTM sales:
2.47x
EV / EBIT:
5.10x
EV / Revenue:
4.43x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
40.84x
Price / Operating cash flow:
22.75x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.32%
Net Income Margin (TTM):
10.98%
Return On Equity:
5.83%
Return On Invested Capital:
1.18%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $32.7B | $42.5B | $45.8B | $11.9B | $11.4B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.95 | $8.72 | $1.51 | $0.52 | $0.51 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $436.1B | $464.4B | $362B | $609.4B | $546.2B | |
| Total Assets | $1.1T | $1.1T | $1.1T | $1.6T | $1.5T | |
| Current Liabilities | $146.3B | $146B | $128.6B | $146.4B | $152B | |
| Total Liabilities | $1T | $1.1T | $996B | $1.5T | $1.5T | |
| Total Equity | $58.3B | $59.2B | $57.1B | $85.8B | $87.6B | |
| Total Debt | $213B | $205.2B | $195.4B | $349.5B | $331.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$37.7B | $122.7B | $7.1B | $11.5B | $15.4B | |
| Cash From Investing | -$11.3B | $106.8B | -$7.8B | $1.3B | -$7.2B | |
| Cash From Financing | -$6.1B | -$98B | -$46.3B | -$40.8B | -$3B | |
| Free Cash Flow | -$39.4B | $121B | $5B | $11.1B | $14.8B | |
UBS
Sector
Market Cap
$107.6B
$628.1M
Price % of 52-Week High
94.17%
87.3%
Dividend Yield
1.33%
1.97%
Shareholder Yield
14.09%
4.02%
1-Year Price Total Return
11.24%
9.14%
Beta (5-Year)
1.159
0.587
Dividend yield:
1.33%
Annualized payout:
$0.70
Payout ratio:
44.92%
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$32.51
200-day SMA
Buy
Level
$31.45
Bollinger Bands (100)
Buy
Level
29.68 - 34.2
Chaikin Money Flow
Buy
Level
186.5M
20-day SMA
Buy
Level
$31.08
Relative Strength Index (RSI14)
Buy
Level
71.85
ADX Line
Buy
Level
22.08
Williams %R
Sell
Level
-2.6634
50-day SMA
Buy
Level
$30.75
MACD (12, 26)
Buy
Level
0.86
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
145.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.5726)
Sell
CA Score
(Annual)
Level (-2.3944)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (7)
Sell
Ohlson Score
Level (2.2247)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.
Stock Forecast FAQ
In the current month, UBS has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The UBS average analyst price target in the past 3 months is $31.60.
-
Where Will UBS Group AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that UBS Group AG share price will drop to $31.60 per share over the next 12 months.
-
What Do Analysts Say About UBS Group AG?
Analysts are divided on their view about UBS Group AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UBS Group AG is a Sell and believe this share price will rise from its current level to $31.50.
-
What Is UBS Group AG's Price Target?
The price target for UBS Group AG over the next 1-year time period is forecast to be $31.60 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is UBS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UBS Group AG is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of UBS?
You can purchase shares of UBS Group AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UBS Group AG shares.
-
What Is The UBS Group AG Share Price Today?
UBS Group AG was last trading at $32.28 per share. This represents the most recent stock quote for UBS Group AG. Yesterday, UBS Group AG closed at $33.75 per share.
-
How To Buy UBS Group AG Stock Online?
In order to purchase UBS Group AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
